Shopping Cart
- Remove All
- Your shopping cart is currently empty
RNPA1000 is an attractive antimicrobial development candidate and RnpA inhibitor.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 mg | $732 | 6-8 weeks | |
100 mg | $1,090 | 6-8 weeks |
Description | RNPA1000 is an attractive antimicrobial development candidate and RnpA inhibitor. |
In vitro | RnpA inhibitor The antibiotic vancomycin and a novel Staphylococcus aureus RnpA inhibitor under pre-clinical development, RNPA1000, were included in these studies. Longer incubations allowed for Staphylococcus aureus colonies to form near the vancomycin-infused cement, indicating that vancomycin may not be suitable for long-term biofilm inhibition in comparison to RNPA1000. Loading glass polyalkenoate cement with either 20-30% RNPA1000 or vancomycin prevented bacterial growth. |
Molecular Weight | 464.31 |
Formula | C23H18BrN3O3 |
Cas No. | 359600-10-5 |
Relative Density. | 1.39 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.